Monitor for additional insider selling in the next 30 days; if isolated, this cluster is likely routine. Check for 10b5-1 plan disclosures in upcoming Form 4s. The coincident grants and sales suggest planned activity, not a reaction to material non-public information.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 2 $200.17entry
- T+1 · 9mo ago +3.43%α +4.35% · $207.04
- T+5 · 8mo ago +2.52%α +3.73% · $205.22
- T+20 · 8mo ago −6.66%α +1.28% · $186.84
- T+60 · 6mo ago +0.37%α −8.96% · $200.91
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple Natera insiders, including the Chief Legal Officer and President/Chief Business Officer, sold shares in the open market, totaling $526,458 in sales over two days. These sales coincided with routine stock award grants of equivalent non-cash value. The total dollar volume represents a small fraction of Natera’s $27.9B market cap.
Key Financial Metrics
Key Facts
- Three insiders conducted open-market sales on March 10, 2026, totaling $526,458.
- Sales were executed at $204.1327 per share by Sheena Jonathan (127 shares, $25,925), Daniel Rabinowitz (1,745 shares, $356,212), and John Fesko (707 shares, $144,322).
- On March 9, the same three individuals received stock grants totaling 4,767 shares with $0 cash value, suggesting the sales may be part of pre-arranged 10b5-1 plans or routine post-grant diversification.
- Total open-market sales represent just 0.0019% of Natera’s $27.9B market cap, indicating minimal economic impact.
- No executives engaged in net buying; all transactions were either sales or non-cash grants.
Financial Impact
$526,458 in open-market share sales over two days
Risk Factors
- Perception risk: Concentrated selling by C-suite members could be interpreted negatively by the market despite likely pre-planned nature.
- Lack of insider buying may signal limited near-term conviction in stock appreciation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (6 trades, 7d window) | cluster-NTRA-1773277539989 |
Track record
63 reports on NTRA
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $288.48 −3.98% settles Nov 17
- Nov 10, 20265d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 10, 20265d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $288.48 −26.23% ▼ −6.97% −2.56% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers